Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Arkin clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Netherlands register with Arkin as lead sponsor. Synced 22 Nov 2026
3Current trials
3Recruiting now
0Drugs in these trials
1Trial register
At a glance

Arkin is the lead sponsor of 3 current clinical trials in our Netherlands register. 3 are recruiting patients now. All registered phases are Not applicable. The most-studied condition is Severe Personality Disorder.

ClinicalTrials.gov trials by status

  • Recruiting3100%

Trials by phase

  • Not applicable3100%
01

Clinical trials sponsored by Arkin

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
The (Cost-)Effectiveness of Generalist Versus Specialist Treatment for Severe Personality Disorders'
NCT06789380 · ClinicalTrials.gov ↗ · Severe Personality Disorder
Not applicable Recruiting 2024-10 Netherlands
From There Towards Now; Intervention for Jewish and Indonesian Post-war Generations
NCT07950800 · ClinicalTrials.gov ↗ · Anxiety Disorders and Symptoms, Depressive Disorder, Personality Disorders
Not applicable Recruiting 2025-04 Netherlands
Hybrid Dialectical Behavior Therapy for Veterans to Further Reduce Emotion Regulation Problems and Trauma Symptoms
NCT07652645 · ClinicalTrials.gov ↗ · PTSD, Emotion Regulation Disorders, Substance Abuse
Not applicable Recruiting 2026-06 Netherlands

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Arkin trials

8 conditions
Severe Personality Disorder1Anxiety Disorders and Symptoms1Depressive Disorder1Personality Disorders1Trauma, Psychological1PTSD1Emotion Regulation Disorders1Substance Abuse1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Netherlands33

A trial with sites in more than one country appears in each of those registers.

04

Questions about Arkin trials

How many clinical trials does Arkin sponsor?

Arkin is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Netherlands register, as of the registry sync on 22 November 2026. Completed and withdrawn studies are not counted.

Are Arkin trials recruiting?

Yes. 3 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.